Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -7.26-24.63-7.9547.4313.49

What is the latest Core EBITDA Growth ratio of SUVEN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SUVEN PHARMACEUTICALS is -7.26 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-7.26
Mar2024-24.63
Mar2023-7.95
Mar202247.43
Mar202113.49

How is Core EBITDA Growth of SUVEN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -7.26
Negative
Mar2024 -24.63
Negative
Mar2023 -7.95
Negative
Mar2022 47.43
251.59
Mar2021 13.49 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹14,433.6 Cr -2.4% -29.1% -63.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹381,326.0 Cr -2.8% -7.5% -12.2% Stock Analytics
DIVIS LABORATORIES ₹160,299.0 Cr -0.6% -5.5% 6.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,821.0 Cr -2.5% 3.5% 21.1% Stock Analytics
CIPLA ₹106,655.0 Cr -3.7% -11.7% -8.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,861.0 Cr -0.7% -4.7% -5.1% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-2.4%

-29.1%

-63.3%

SENSEX

0.8%

-2.9%

8.1%


You may also like the below Video Courses